Medpace Holdings Inc. Company Profile
NASDAQ: MEDPHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
Market open · Delayed 15 min · as of Oct 9, 10:19 AM ET
Medpace at a glance
Medpace Holdings Inc. (NASDAQ: MEDP) is a Biotechnology: Commercial Physical & Biological Resarch company in the Health Care sector headquartered in Cincinnati, OH. Medpace is led by Dr. August James Troendle M.D. and employs about 6,500 people. The company's shares have traded publicly since 2016.
At a market capitalization of $16.87 billion, it is considered a large-cap company. Its SEC Central Index Key (CIK) is 0001668397, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Medpace do?
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Business description based on the company's public filings.
Company information
- Legal name
- Medpace Holdings Inc.
- Ticker
- NASDAQ: MEDP
- Sector
- Health Care
- Industry
- Biotechnology: Commercial Physical & Biological Resarch
- CEO
- Dr. August James Troendle M.D.
- Employees
- 6,500
- Headquarters
- 5375 Medpace Way, Cincinnati, OH, United States
- Phone
- 513 579 9911
- Website
- medpace.com
- IPO year
- 2016
- Market cap
- $16.87B
- SEC CIK
- 0001668397
- Latest annual report
- 10-K · Feb 10, 2026
Companies similar to Medpace
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CRLCharles River Laboratories International Inc. | 303.37 | +1.80% | $14.61B | vs MEDP |
| ICLRICON plc | 168.32 | +2.32% | $12.99B | vs MEDP |
| INCYIncyte Corp. | 112.79 | +0.04% | $22.86B | vs MEDP |
| ABSIAbsci Corporation | 9.95 | +11.30% | $1.71B | vs MEDP |
| OABIOmniAb Inc. | 4.83 | +3.65% | $702.24M | vs MEDP |
| NRCNRC Health | 20.42 | -0.01% | $451.62M | vs MEDP |
| MXCTMaxCyte Inc. | 1.03 | +0.49% | $105.79M | vs MEDP |
| ONMDOneMedNet Corp Class A | 4.85 | +0.52% | $28.22M | vs MEDP |